Published online before print March 27, 2008, doi: 10.1161/STROKEAHA.107.508325
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:2073.)
© 2008 American Heart Association, Inc.
Original Contributions |
Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia
From the Department of Anesthesiology & Peri–Operative Medicine (W.Z., A.A., Y.K.A., J.J.I., N.J.A.), and the Department of Physiology & Pharmacology (J.J.I., A.E.D., D.R.K., N.J.A.), Oregon Health and Science University, Portland, Ore; Neurosurgery Sagamihara–chuo Hospital (T.O.), Kanagawa, Japan; and the Department of Neurosurgery (N.S.), Toho University, Japan.
Correspondence to Nabil J. Alkayed, MD, PhD, Oregon Health & Science University, Department of Anesthesiology & Peri–Operative Medicine, 3181 SW Sam Jackson Park Road, UHS-2, Portland, OR 97239-3098. E-mail alkayedn{at}ohsu.edu
Background and Purpose— Cytochrome P450 epoxygenase metabolizes arachidonic acid to epoxyeicosatrienoic acids (EETs). EETs are produced in the brain and perform important biological functions, including vasodilation and neuroprotection. However, EETs are rapidly metabolized via soluble epoxide hydrolase (sEH) to dihydroxyeicosatrienoic acids (DHETs). We tested the hypothesis that sEH gene deletion is protective against focal cerebral ischemia through enhanced collateral blood flow.
Methods— sEH knockout (sEHKO) mice with and without EETs antagonist 14, 15 epoxyeicosa-5(Z)-enoic acid (EEZE) were subjected to 2-hour middle cerebral artery occlusion (MCAO), and infarct size was measured at 24 hours of reperfusion and compared to wild-type (WT) mice. Local CBF rates were measured at the end of MCAO using iodoantipyrine (IAP) autoradiography, sEH protein was analyzed by Western blot and immunohistochemistry, and hydrolase activity and levels of EETs/DHETs were measured in brain and plasma using LC-MS/MS and ELISA, respectively.
Results— sEH immunoreactivity was detected in WT, but not sEHKO mouse brain, and was localized to vascular and nonvascular cells. 14,15-DHET was abundantly present in WT, but virtually absent in sEHKO mouse plasma. However, hydrolase activity and free 14,15-EET in brain tissue were not different between WT and sEHKO mice. Infarct size was significantly smaller, whereas regional cerebral blood flow rates were significantly higher in sEHKO compared to WT mice. Infarct size reduction was recapitulated by 14,15-EET infusion. However, 14,15-EEZE did not alter infarct size in sEHKO mice.
Conclusions— sEH gene deletion is protective against ischemic stroke by a vascular mechanism linked to reduced hydration of circulating EETs.
Key Words: stroke • cerebral ischemia • EETs • EEZE, P450 epoxygenase • eicosanoids • neuroprotection • CBF • sEH • EPHX2
This article has been cited by other articles:
 |
|
 |
|
  A. N. Simpkins, R. D. Rudic, D. A. Schreihofer, S. Roy, M. Manhiani, H.-J. Tsai, B. D. Hammock, and J. D. Imig Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection Am. J. Pathol., June 1, 2009; 174(6): 2086 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Iliff, R. Wang, D. C. Zeldin, and N. J. Alkayed Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1352 - H1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Motoki, M. J. Merkel, W. H. Packwood, Z. Cao, L. Liu, J. Iliff, N. J. Alkayed, and D. M. Van Winkle Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2128 - H2134. [Abstract] [Full Text] [PDF]
|
|